Related Experiment Video

Updated: May 8, 2026

The Intra-Aortic Balloon Pump
06:13

The Intra-Aortic Balloon Pump

Published on: February 5, 2021

Intra-Aortic Balloon Pump (IABP) in cardiogenic shock

Georg Fuernau1, Holger Thiele

  • 1Department of Internal Medicine/Cardiology, University of Leipzig - Heart Center, Leipzig, Germany.

Current Opinion in Critical Care
|September 3, 2013
PubMed

Insights

Intra-aortic balloon pumping (IABP) shows no survival benefit for cardiogenic shock patients with myocardial infarction. Recent trials challenge previous recommendations, indicating IABP is not generally recommended. Further research is needed for alternative treatments.

Area of Science:

  • Cardiology
  • Critical Care Medicine
  • Medical Devices

Background:

  • Mortality rates for cardiogenic shock post-myocardial infarction remain high despite treatment advances.
  • Intra-aortic balloon pumping (IABP) is a common hemodynamic support device, but lacked robust evidence for survival benefit.

Purpose of the Study:

  • To review the current evidence and guidelines regarding the use of IABP in cardiogenic shock.
  • To assess the impact of recent randomized trials on IABP recommendations.

Main Methods:

  • Review of recent meta-analyses and large-scale randomized trials.
  • Analysis of guideline changes from European and American societies.

Main Results:

  • A recent meta-analysis suggested higher mortality with IABP after primary percutaneous intervention.
  • A large randomized trial found no significant 30-day mortality benefit for IABP in myocardial infarction complicated by cardiogenic shock.
  • Guideline recommendations for IABP in cardiogenic shock have been downgraded.

Conclusions:

  • No general recommendation for IABP in cardiogenic shock can be made.
  • Recent trial results should inform future guideline revisions.
  • Development of alternative treatments and validated algorithms for active assist devices is necessary.
Abstract

More Related Videos

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

Related Concept Videos

Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...